Showing results (1651-1660 of 1,669) with videos related to

Sort By:
Pageof 167
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2026
A Phase 2 Trial of Niraparib in Patients with Advanced Pancreatic Cancer Harboring Pathogenic Variants in ATM, BRCA1, BRCA2, PALB2, and CHEK2Brandon M Huffman, Miklos Diossy, Matthew B Yurgelun, et al.
The Lancet. Respiratory Medicine|March 24, 2026
Endotracheal surfactant for infants with life-threatening bronchiolitis (BESS): a randomised, blinded, sham-controlled, phase 2 trialMalcolm G Semple, Chloe Donohue, Laura Price, et al.
Journal of Human Genetics|January 20, 2021
Variation in the SERPINA6/SERPINA1 locus alters morning plasma cortisol, hepatic corticosteroid binding globulin expression, gene expression in peripheral tissues, and risk of cardiovascular diseaseAndrew A Crawford, Sean Bankier, Elisabeth Altmaier, et al.
Journal for Immunotherapy of Cancer|January 25, 2024
Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term respondersBrandon M Huffman, Harshabad Singh, Lestat R Ali, et al.
JAMA|September 11, 2023
Two-Year Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants: Follow-Up of the OPTIMIST-A Randomized Clinical TrialPeter A Dargaville, C Omar F Kamlin, Francesca Orsini, et al.
Nature Ecology & Evolution|January 12, 2024
Hagfish genome elucidates vertebrate whole-genome duplication events and their evolutionary consequencesDaqi Yu, Yandong Ren, Masahiro Uesaka, et al.
JCO Precision Oncology|September 2, 2025
Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic CancerRishi Surana, Micaela Morgado, Ashwin Somasundaram, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2021
Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal CancerAparna R Parikh, Emily E Van Seventer, Giulia Siravegna, et al.
Nature Medicine|January 26, 2023
Combined PD-1, BRAF and MEK inhibition in BRAF<sup>V600E</sup> colorectal cancer: a phase 2 trialJun Tian, Jonathan H Chen, Sherry X Chao, et al.
Nature Medicine|November 21, 2019
Author Correction: Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancersAparna R Parikh, Ignaty Leshchiner, Liudmila Elagina, et al.
Pageof 167